Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 50

Publication Record

Connections

RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT.
Kryshtal DO, Blackwell DJ, Egly CL, Smith AN, Batiste SM, Johnston JN, Laver DR, Knollmann BC
(2021) Circ Res 128: 321-331
MeSH Terms: Action Potentials, Animals, Anti-Arrhythmia Agents, Calcium Channel Blockers, Calcium Signaling, Calsequestrin, Disease Models, Animal, Female, Flecainide, HEK293 Cells, Heart Rate, Humans, Male, Mice, Knockout, Myocytes, Cardiac, Phosphorylation, Ryanodine Receptor Calcium Release Channel, Sarcoplasmic Reticulum, Sheep, Domestic, Tachycardia, Ventricular, Voltage-Gated Sodium Channel Blockers
Added December 21, 2020
1 Communities
0 Members
0 Resources
21 MeSH Terms
Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
Kannankeril PJ, Moore JP, Cerrone M, Priori SG, Kertesz NJ, Ro PS, Batra AS, Kaufman ES, Fairbrother DL, Saarel EV, Etheridge SP, Kanter RJ, Carboni MP, Dzurik MV, Fountain D, Chen H, Ely EW, Roden DM, Knollmann BC
(2017) JAMA Cardiol 2: 759-766
MeSH Terms: Adolescent, Adrenergic beta-Antagonists, Anti-Arrhythmia Agents, Cross-Over Studies, Death, Sudden, Cardiac, Defibrillators, Implantable, Drug Therapy, Combination, Exercise, Exercise Test, Female, Flecainide, Humans, Male, Maximum Tolerated Dose, Single-Blind Method, Tachycardia, Ventricular, Young Adult
Added March 24, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.
Van Wagoner DR, Piccini JP, Albert CM, Anderson ME, Benjamin EJ, Brundel B, Califf RM, Calkins H, Chen PS, Chiamvimonvat N, Darbar D, Eckhardt LL, Ellinor PT, Exner DV, Fogel RI, Gillis AM, Healey J, Hohnloser SH, Kamel H, Lathrop DA, Lip GY, Mehra R, Narayan SM, Olgin J, Packer D, Peters NS, Roden DM, Ross HM, Sheldon R, Wehrens XH
(2015) Heart Rhythm 12: e5-e29
MeSH Terms: Anti-Arrhythmia Agents, Atrial Fibrillation, Biomedical Research, Electric Countershock, Humans, Needs Assessment, Risk Factors
Added January 20, 2015
0 Communities
2 Members
0 Resources
7 MeSH Terms
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.
Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, Calkins H, Aranki S, Kaneko T, Cassivi S, Smith SC, Darbar D, Wee JO, Waddell TK, Amar D, Adler D, American Association for Thoracic Surgery
(2014) J Thorac Cardiovasc Surg 148: e153-93
MeSH Terms: Anti-Arrhythmia Agents, Atrial Fibrillation, Atrial Flutter, Catheter Ablation, Electric Countershock, Humans, Predictive Value of Tests, Risk Assessment, Risk Factors, Societies, Medical, Thoracic Surgical Procedures, Treatment Outcome
Added January 20, 2015
0 Communities
1 Members
0 Resources
12 MeSH Terms
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. Executive summary.
Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, Calkins H, Aranki S, Kaneko T, Cassivi S, Smith SC, Darbar D, Wee JO, Waddell TK, Amar D, Adler D, American Association of Thoracic Surgery
(2014) J Thorac Cardiovasc Surg 148: 772-91
MeSH Terms: Anti-Arrhythmia Agents, Atrial Fibrillation, Atrial Flutter, Catheter Ablation, Electric Countershock, Humans, Predictive Value of Tests, Risk Assessment, Risk Factors, Societies, Medical, Thoracic Surgical Procedures, Treatment Outcome
Added January 20, 2015
0 Communities
1 Members
0 Resources
12 MeSH Terms
A genome-wide association study to identify genomic modulators of rate control therapy in patients with atrial fibrillation.
Kolek MJ, Edwards TL, Muhammad R, Balouch A, Shoemaker MB, Blair MA, Kor KC, Takahashi A, Kubo M, Roden DM, Tanaka T, Darbar D
(2014) Am J Cardiol 114: 593-600
MeSH Terms: Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Atrioventricular Node, DNA, Female, Follow-Up Studies, Genome-Wide Association Study, Genotype, Heart Rate, Humans, Male, Middle Aged, Phenotype, Polymorphism, Single Nucleotide, Retrospective Studies, SOXD Transcription Factors, Time Factors
Added January 20, 2015
0 Communities
3 Members
0 Resources
18 MeSH Terms
Severity of obstructive sleep apnea influences the effect of genotype on response to anti-arrhythmic drug therapy for atrial fibrillation.
Goyal SK, Wang L, Upender R, Darbar D, Monahan K
(2014) J Clin Sleep Med 10: 503-7
MeSH Terms: Anti-Arrhythmia Agents, Atrial Fibrillation, Female, Genetic Predisposition to Disease, Genotype, Genotyping Techniques, Humans, Male, Middle Aged, Pilot Projects, Polysomnography, Severity of Illness Index, Sleep Apnea, Obstructive, Treatment Outcome
Added January 20, 2015
0 Communities
1 Members
0 Resources
14 MeSH Terms
Personalized medicine to treat arrhythmias.
Roden DM
(2014) Curr Opin Pharmacol 15: 61-7
MeSH Terms: Animals, Anti-Arrhythmia Agents, Arrhythmias, Cardiac, Humans, Precision Medicine
Added June 26, 2014
0 Communities
1 Members
0 Resources
5 MeSH Terms
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines
(2014) J Am Coll Cardiol 64: e1-76
MeSH Terms: Anti-Arrhythmia Agents, Anticoagulants, Arrhythmias, Cardiac, Atrial Fibrillation, Autonomic Nervous System, C-Reactive Protein, Cardiac Output, Low, Catheter Ablation, Comorbidity, Defibrillators, Implantable, Echocardiography, Transesophageal, Electric Countershock, Electrocardiography, Fibrinolytic Agents, Heart Atria, Heart Conduction System, Humans, Inflammation, Natriuretic Peptide, Brain, Oxidative Stress, Pacemaker, Artificial, Platelet Aggregation Inhibitors, Renin-Angiotensin System, Risk Assessment, Risk Factors, Septal Occluder Device, Stroke, Thromboembolism, Ventricular Remodeling
Added May 27, 2014
0 Communities
1 Members
0 Resources
29 MeSH Terms
Melatonin reduces tachycardia in postural tachycardia syndrome: a randomized, crossover trial.
Green EA, Black BK, Biaggioni I, Paranjape SY, Bagai K, Shibao C, Okoye MC, Dupont WD, Robertson D, Raj SR
(2014) Cardiovasc Ther 32: 105-12
MeSH Terms: Administration, Oral, Adult, Anti-Arrhythmia Agents, Blood Pressure, Cross-Over Studies, Drug Administration Schedule, Female, Heart Rate, Humans, Male, Melatonin, Norepinephrine, Postural Orthostatic Tachycardia Syndrome, Sympathetic Nervous System, Tennessee, Time Factors, Treatment Outcome, Young Adult
Added March 21, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms